How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. The market approach is a method for determining the value of an ...

The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...

就在昨天，新加坡国立大学、中国人民大学、复旦大学等多所顶尖机构联合发布了一篇AI Agent 记忆（Memory）综述。 当前的 LLM 应用开发正面临严重的“记忆碎片化”问题：我们有用于短期记忆的 KV Cache，有用于知识检索的 RAG，还有用于长期交互的 MemGPT 类架构，但缺乏统一的理论指导。这篇综述不仅是对现有工作的盘点，更是一份解决“灾难性遗忘”与“上下文溢出”的系统方案。它详细 ...

So many productivity methods ask you to prioritize your daily tasks by considering how much time or effort they'll require, then tackling the resource-heavy ones first. For some people, that's a solid ...